| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jan―22 |
Dysautonomia after COVID-19 infection: A case report |
C.H. Vera-Cáceres, M. García-Huguet, A. Gil de Genover, S.D. Sagula, L. Martín Muñóz, D. López Domínguez |
| 2 |
[GO] |
2025―Aug―04 |
Association between encephalopathy and clinical outcomes of COVID-19: Findings from the Philippine CORONA Study |
V.M.M. Anlacan, F.G.C. Gabriel, R.D.G. Jamora, E.Q. Villanueva III, M.C.C. Sy, M.H.L. Lee Yu, A.I. Espiritu |
| 3 |
[GO] |
2025―Mai―20 |
Variables associated with cognitive alterations in a cohort of COVID-19 survivors at a third-level hospital in Mexico |
M. Rodríguez-Rodríguez, Y. Rodríguez-Agudelo, F.J. Soto-Moreno, A. García-Santos, D. López-González, M. González-Navarro, F. Paz-Rodríguez, M. Chávez-Oliveros, S. Lozano-Tovar, K. González-Alonso, A. Castorena-Maldonado, R. Carrillo-Mezo, O. Marrufo-Meléndez, A. Gutiérrez-Romero, M. Del Río Quiñones, A. Arauz-Góngora, S. Avila-Rios |
| 4 |
[GO] |
2024―Nov―01 |
Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain |
D. García-Azorín, E. Lázaro, D. Ezpeleta, R. Lecumberri, R. de la Cámara, M. Castellanos, C. Iñiguez Martínez, L. Quiroga-González, G. Elizondo Rivas, A. Sancho-López, P. Rayón Iglesias, E. Segovia, C. Mejías, D. Montero Corominas |
| 5 |
[GO] |
2024―Sep―02 |
Valproic acid could help in the fight against COVID-19: A case-control study |
O. Moreno-Pérez, E. Merino, J. Manuel Ramos, J. Carlos Rodríguez, C. Diaz, P. Mas, S. Reus, R. Sánchez-Martínez, V. Boix, P. Chico-Sánchez, J. Sánchez-Payá, J. Portilla |
| 6 |
[GO] |
2024―Mrz―27 |
Covid-19 in Parkinson's Disease treated by drugs or brain stimulation |
M. Salari, M. Etemadifar, A. Zali, Z. Aminzade, I. Navalpotro-Gomez, S. Tehrani Fateh |
| 7 |
[GO] |
2024―Mrz―07 |
Osmotic demyelination syndrome amidst COVID-19: A case report with literature review |
G. Dimitrov, D. Naeva, R. Duparinova, S. Stratieva, V. Manev, K. Prinova |
| 8 |
[GO] |
2024―Feb―20 |
Encephalitis after COVID-19 vaccination |
R. López-González, M.A. Otálvaro-Rendón, L. Quintero-Gutiérrez |
| 9 |
[GO] |
2023―Okt―17 |
Symptomatic dialysis disequilibrium syndrome after SARS-CoV-2 infection, about a case |
J. Lapeña-Motilva, S. Gómez-Enjuto, V. Hernándo-Requejo, N. Huertas-González |
| 10 |
[GO] |
2023―Jul―09 |
Incidence of Bell’s palsy after Coronavirus disease (COVID-19) vaccination: a systematic review and meta-analysis |
Atena Soltanzadi, Omid Mirmosayyeb, Amin Momeni Moghaddam, Hamed Ghoshouni, Mahsa Ghajarzadeh |
| 11 |
[GO] |
2023―Jun―19 |
The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness |
R. Keikha, S.M. Hashemi-Shahri, A. Jebali |
| 12 |
[GO] |
2023―Apr―27 |
Mild sensory symptoms during SARS-CoV-2 infection among healthcare professionals |
D. Gayoso Cantero, E. Cantador Pavón, E. Pérez Fernández, M.E. Novillo López |
| 13 |
[GO] |
2022―Dez―01 |
Functional neurological disorders in post COVID-19 patients. Case series |
S. Albu, Z. Guven, M. Vallés, H. Kumru |
| 14 |
[GO] |
2022―Nov―30 |
Parsonage-Turner syndrome associated with COVID-19: About 2 family cases |
C.E. Pivaral Cabrera, A.R. Rincón Sánchez, N.O. Dávalos Rodríguez, S.A. Ramirez Garcia |
| 15 |
[GO] |
2022―Okt―27 |
‘Wine Glass’ sign following COVID-19 vaccination in a previously healthy adult |
R. Ghosh, S. Dutta, M. Ghosh, J. Benito-León |
| 16 |
[GO] |
2022―Okt―23 |
Neurological manifestations associated with COVID-19 vaccine |
R. Alonso Castillo, J.C. Martínez Castrillo |
| 17 |
[GO] |
2022―Okt―12 |
Hashimoto encephalopathy after vaccination against SARS-CoV-2 |
M. Viscasillas Sancho, C. Moreno Loscertales, S. García Rubio, D. Sagarra Mur |
| 18 |
[GO] |
2022―Okt―01 |
Parkinsonism with akinetic mutism following osmotic demyelination syndrome in a SARS-CoV-2 infected elderly diabetic woman: A case report |
R. Ghosh, A. Ray, D. Roy, S. Das, S. Dubey, J. Benito-León |
| 19 |
[GO] |
2022―Mai―07 |
Bilateral chorea as a manifestation of cerebral venous sinus thrombosis associated with COVID-19 |
A. Revert Barberà, I. Estragués Gazquez, M.B. Beltrán Mármol, A. Rodríguez Campello |
| 20 |
[GO] |
2022―Mai―06 |
Haemorrhage within the cavity of a porencephalic cyst: a haemorrhagic complication in a patient with COVID-19 |
I. Muro, C. Ramos, A. Barbosa, J. Vivancos |
| 21 |
[GO] |
2022―Mrz―18 |
Antineuronal antibodies: Anti-recoverin in neurological syndromes without retinopathy. SARS-CoV2 infection as a trigger |
G.M. Ávila, E.E. Escamilla, A.P. González, J.A.M. Corral, C.P. Fernández, A.R. Marcos |
| 22 |
[GO] |
2021―Okt―13 |
Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications |
E. Caronna, V. José Gallardo, A. Alpuente, M. Torres-Ferrus, N.M. Sánchez-Mateo, J. Viguera-Romero, A.C. López-Veloso, A. López-Bravo, A.B. Gago-Veiga, P. Irimia Sieira, J. Porta-Etessam, S. Santos-Lasaosa, P. Pozo-Rosich |
| 23 |
[GO] |
2021―Sep―15 |
COVID-19 related strokes: Pandora's Box may open as the p(c)lot thickens! |
R. Magoon |
| 24 |
[GO] |
2021―Aug―03 |
SARS-CoV-2 infection: possible underdiagnosis of cerebral venous sinus thrombosis |
M.L. Almarcha-Menargues, M.M. Martínez-Martínez, J. Fernández-Travieso |
| 25 |
[GO] |
2021―Jul―28 |
Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine |
J.A. Crespo Burillo, C. Loriente Martínez, C. García Arguedas, F.J. Mora Pueyo |
| 26 |
[GO] |
2021―Jul―22 |
Bell’s palsy following COVID-19 vaccination: A case report |
G. Gómez de Terreros Caro, S. Gil Díaz, M. Pérez Alé, M.L. Martínez Gimeno |
| 27 |
[GO] |
2021―Jul―22 |
Acute transverse myelitis following SARS-CoV-2 infection |
C. Jauregui-Larrañaga, A. Ostolaza-Ibáñez, M. Martín-Bujanda |
| 28 |
[GO] |
2021―Jul―22 |
Parsonage-Turner syndrome post-infection by SARS-CoV-2: a case report |
M. Alvarado, Y. Lin-Miao, M. Carrillo-Arolas |
| 29 |
[GO] |
2021―Jun―05 |
Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: regional analysis of the impact of COVID-19 |
H. Tejada Meza, Á. Lambea Gil, C. Villar Yus, C. Pérez Lázaro, M.P. Navarro Pérez, I. Campello Morer, Á. Giménez Muñoz, J. Artal Roy, O. Alberti González, N. Hernando Quintana, P. Ruiz Palomino, J.A. Crespo Burillo, C. García Arguedas, L. Ballester Marco, M. Palacin Larroy, M. Seral Moral, J. Marta Moreno |
| 30 |
[GO] |
2021―Jun―01 |
SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis |
R. Piñar Morales, M.A. Ramírez Rivas, F.J. Barrero Hernández |
| 31 |
[GO] |
2021―Mai―29 |
Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination |
|
| 32 |
[GO] |
2021―Feb―21 |
Relation between COVID-19 and Guillain-Barre syndrome in adults. Systematic review |
F. Araya-Quintanilla, I. Valdés-Orrego, H. Gutiérrez-Espinoza |
| 33 |
[GO] |
2021―Feb―11 |
Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry |
M.J. Abenza Abildúa, S. Atienza, G. Carvalho Monteiro, M.E. Erro Aguirre, L. Imaz Aguayo, E. Freire Álvarez, D. García-Azorín, I. Gil-Olarte Montesinos, L.B. Lara Lezama, M.P. Navarro Pérez, J.R. Pérez Sánchez, F. Romero Delgado, B. Serrano Serrano, E. Villarreal Vitorica, D. Ezpeleta Echávarri |
| 34 |
[GO] |
2021―Feb―07 |
Impact of the COVID-19 pandemic on a cohort of ALS patients in Catalonia |
B. Bertran Recasens, M. Povedano Panadés, M.A. Rubio |
| 35 |
[GO] |
2021―Feb―05 |
Isolated syncope as a form of presentation of COVID-19 infection |
I. Hernandez Pérez, B. Talavera de la Esperanza, G. Valle Peñacoba, D. Garcia Azorin |
| 36 |
[GO] |
2021―Feb―05 |
Substance P, proinflammatory cytokines, transient receptor potential vanilloid subtype 1 and COVID-19: a working hypothesis |
E.E. Aguirre-Siancas, E. Colona-Vallejos, E. Ruiz-Ramirez, M. Becerra-Bravo, L. Alzamora-Gonzales |
| 37 |
[GO] |
2020―Dez―16 |
COVID-19 and the forgotten pandemic: Follow-up of neurocognitive disorders during lockdown in Argentina |
M. Sorbara, H.G. Graviotto, G.M. Lage-Ruiz, C.M. Turizo-Rodriguez, L.A. Sotelo-López, A. Serra, C. Gagliardi, G. Heinemann, P. Martinez, F. Ces-Magliano, C.M. Serrano |
| 38 |
[GO] |
2020―Dez―15 |
Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection |
J. Porta-Etessam, M. Yus, N. González García, A. Valcarcel, J. Barrado-Cuchillo, J. Pérez-Somarriba |
| 39 |
[GO] |
2020―Okt―30 |
Social and professional consequences of COVID-19 lockdown in patients with multiple sclerosis from 2 very different populations |
G.-X. Zhang, C. Sanabria, D. Martinez, W.-T. Zhang, S.-S. Gao, A. Alemán, A. Granja, C. Páramo, M. Borges, G. Izquierdo |
| 40 |
[GO] |
2020―Okt―09 |
Neurological complications in critical patients with COVID-19 |
M.J. Abenza-Abildúa, M.T. Ramírez-Prieto, R. Moreno-Zabaleta, N. Arenas-Valls, M.A. Salvador-Maya, C. Algarra-Lucas, B. Rojo Moreno-Arrones, B. Sánchez-Cordón, J. Ojeda-Ruíz de Luna, C. Jimeno-Montero, F.J. Navacerrada-Barrero, C. Borrue-Fernández, E. Malmierca-Corral, P. Ruíz-Seco, P. González-Ruano, I. Palmí-Cortés, J. Fernández-Travieso, M. Mata-Álvarez de Santullano, M.L. Almarcha-Menargues, G. Gutierrez-Gutierrez, J.A. Palacios Castaño, R. Alonso Esteban, N. Gonzalo-García, C. Pérez-López |
| 41 |
[GO] |
2020―Okt―09 |
Relevance of neuroimaging in publications on COVID-19 and stroke |
J.P. Martínez-Barbero, P. Tomás-Muñoz, R. Martínez-Moreno |
| 42 |
[GO] |
2020―Okt―09 |
Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2 Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection |
G. Alvarez Bravo, L. RamióTorrentà |
| 43 |
[GO] |
2020―Okt―09 |
Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology’s Headache Study Group |
N. Morollón, R. Belvís, A. De Dios, N. Pagès, C. González-Oria, G. Latorre, S. Santos-Lasaosa |
| 44 |
[GO] |
2020―Okt―08 |
Smell and taste disorders in Spanish patients with mild COVID-19 |
J. Barón-Sánchez, C. Santiago, G. Goizueta-San Martín, R. Arca, R. Fernández |
| 45 |
[GO] |
2020―Okt―08 |
Relation between COVID-19 and Guillain-Barré syndrome in adults: A systematic review |
LM Trujillo Gittermann, SN Valenzuela Feris, A von Oetinger Giacoman |
| 46 |
[GO] |
2020―Okt―08 |
Convulsive status epilepticus as a possible symptom of COVID-19 in a patient with intellectual disability and autistic spectrum disorder |
C. Peña-Salazar, M. López Cuiña, V. Chavarría, B. Robles Olmo |
| 47 |
[GO] |
2020―Okt―08 |
Therapeutic approaches to multiple sclerosis in Central America and the Caribbean during the COVID-19 pandemic |
V.M. Rivera, F. Gracia, A. Díaz |
| 48 |
[GO] |
2020―Okt―08 |
Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report |
L. Ordoñez-Boschetti, C.M. Torres-Romero, M.J. Ortiz De Leo |
| 49 |
[GO] |
2020―Okt―08 |
Guillain - Barré syndrome as the first manifestation of SARS-CoV-2 infection |
O. Barrachina-Esteve, A. Palau Domínguez, I. Hidalgo Torrico, M.L. Viguera Martinez |
| 50 |
[GO] |
2020―Okt―07 |
Case fatality of COVID-19 in patients with neurodegenerative dementia |
JA Reyes-Bueno, N Mena-Vázquez, T Ojea-Ortega, MM Gonzalez-Sotomayor, P Cabezudo-Garcia, NL Ciano-Petersen, G Pons-Pons, MV Castro-Sánchez, PJ Serrano-Castro |
| 51 |
[GO] |
2020―Okt―07 |
Myopathy associated with serious SARS-CoV-2 infection |
M.J. Abenza Abildúa, M.T. Ramírez Prieto, R. Moreno Zabaleta, C. Algarra Lucas, C. Pérez López |
| 52 |
[GO] |
2020―Sep―06 |
Erratum to ‘‘Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: Safety algorithm’’ [Neurologia. 2020;35(6):357-362] |
G. Valero-López, E. Carreón-Guarnizo, R. Hernández-Clares, F. Iniesta-Martínez, J. Jiménez-Veiga, A. Moreno-Docon, M.A. Iborra-Bendicho, E. Aznar-Robles, M.F. Hellín-Gil, A. Morales-Ortiz, J.E. Meca-Lallana |
| 53 |
[GO] |
2020―Jul―12 |
Tremor and ataxia in COVID-19 |
A.M. Diezma-Martín, M.I. Morales-Casado, N. García Alvarado, A. Vadillo Bermejo, N. López-Ariztegui, M.A. Sepúlveda Berrocal |
| 54 |
[GO] |
2020―Jul―12 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases |
C. Guijarro-Castro, M. Rosón-González, A. Abreu, A. García-Arratibel, M. Ochoa-Mulas |
| 55 |
[GO] |
2020―Jul―12 |
Emergency implementation of a teleneurology service at the neuromuscular diseases unit of Hospital Regional de Málaga during the SARS-CoV-2 pandemic |
J. Romero-Imbroda, V. Reyes-Garrido, N.L. Ciano-Petersen, P.J. Serrano-Castro |
| 56 |
[GO] |
2020―Jul―12 |
The future of neurorehabilitation after the SARS-CoV-2 pandemic |
A. Juárez-Belaúnde, C. Colomer Font, S. Laxe, M. Ríos-Lago, J. Ferri Campos |
| 57 |
[GO] |
2020―Jul―04 |
Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives |
Alba López-Bravo, David García-Azorín, Roberto Belvís, Carmen González-Oria, Germán Latorre, Sonia Santos-Lasaosa, Ángel Luis Guerrero-Peral |
| 58 |
[GO] |
2020―Jul―04 |
Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan |
B. Fuentes, M. Alonso de Leciñana, P. Calleja-Castaño, J. Carneado-Ruiz, J. Egido-Herrero, A. Gil-Núñez, J. Masjuán-Vallejo, J. Vivancos-Mora, J. Rodríguez-Pardo, N. Riera-López, Á. Ximénez-Carrillo, A. Cruz-Culebras, C. Gómez-Escalonilla, E. Díez-Tejedor |
| 59 |
[GO] |
2020―Jul―04 |
Pulse immunosuppressive therapy for multiple sclerosis during the SARS-CoV-2 lockdown de-escalation plan: safety algorithm |
Gabriel Valero-López, Ester Carreón-Guarnizo, Rocio Hernández-Clares, Francisca Iniesta-Martínez, Judith Jiménez-Veiga, Antonio Moreno-Docon, Maria Asuncion Iborra-Bendicho, Ana Morales-Ortiz, Jose Eustasio Meca-Lallana |
| 60 |
[GO] |
2020―Jun―11 |
The role of scientific journal editors during the COVID-19 pandemic |
J. Matias-Guiu |
| 61 |
[GO] |
2020―Jun―04 |
COVID-19 and concomitant neurological infections |
V. Romero Cantero, S. Moreno Pulido, M. Duque Holgado, I. Casado Naranjo |
| 62 |
[GO] |
2020―Jun―04 |
OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection |
S. Santos-Lasaosa, J. Porta-Etessam |
| 63 |
[GO] |
2020―Mai―29 |
Stroke as a complication and prognostic factor of COVID-19 |
J.M. Trejo Gabriel y Galán |
| 64 |
[GO] |
2020―Mai―28 |
Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association? |
J.M. Barrios-López, I. Rego-García, C. Muñoz Martínez, J.C. Romero-Fábrega, M. Rivero Rodríguez, J.A. Ruiz Giménez, F. Escamilla-Sevilla, A. Mínguez-Castellanos, M.D. Fernández Pérez |
| 65 |
[GO] |
2020―Mai―21 |
Neurological infections during the COVID-19 epidemic |
R. López-Blanco, R. Cazorla-Garcia, N. Barbero-Bordallo, J. Fernández-Ferro |
| 66 |
[GO] |
2020―Mai―21 |
The epilepsy unit during the COVID-19 epidemic: The role of telemedicine and the effects of confinement on patients with epilepsy |
V. Hernando-Requejo, N. Huertas-González, J. Lapeña-Motilva, G. Ogando-Durán |
| 67 |
[GO] |
2020―Mai―21 |
Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey |
J. Matías-Guiu, J.A. Matias-Guiu, J. Alvarez-Sabin, J. Ramon Ara, J. Arenillas, I. Casado-Naranjo, M. Castellanos, M.D. Jimenez-Hernandez, J.M. Lainez-Andres, E. Moral, A. Morales, A. Rodriguez-Antigüedad, T. Segura, P. Serrano-Castro, E. Diez-Tejedor |
| 68 |
[GO] |
2020―Mai―21 |
Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection |
S. Escalada Pellitero, L. Garriga Ferrer-Bergua |
| 69 |
[GO] |
2020―Mai―11 |
Neurology during the pandemic. Is COVID-19 changing the organisation of Neurology Departments? |
F.J. Hernández Ramos, A. Palomino García, M.D. Jiménez Hernández |
| 70 |
[GO] |
2020―Mai―11 |
Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations |
J. Rodríguez-Pardo, B. Fuentes, M. Alonso de Leciñana, J. Campollo, P. Calleja Castaño, J. Carneado Ruiz, J. Egido Herrero, R. García Leal, A. Gil Núñez, J.F. Gómez Cerezo, A. Martín Martínez, J. Masjuán Vallejo, B. Palomino Aguado, N. Riera López, R. Simón de las Heras, J. Vivancos Mora, E. Díez Tejedor |
| 71 |
[GO] |
2020―Mai―08 |
A neurology department at a tertiary-level hospital during the COVID-19 pandemic |
F. Grandas, J.M. García Domínguez, F. Díaz Otero |
| 72 |
[GO] |
2020―Mai―08 |
Fatal Guillain-Barre syndrome after infection with SARS-CoV-2 |
J. Marta-Enguita, I. Rubio-Baines, I. Gastón-Zubimendi |
| 73 |
[GO] |
2020―Mai―08 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection |
A. Velayos Galán, P. del Saz Saucedo, F .Peinado Postigo, E. Botia Paniagua |
| 74 |
[GO] |
2020―Mai―08 |
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: A delayed pandemic? |
P.J. Serrano-Castro, G. Estivill-Torrús, P. Cabezudo-García, J.A. Reyes-Bueno, N. Ciano Petersen, M.J. Aguilar-Castillo, J. Suárez-Pérez, M.D. Jiménez-Hernández, M.Á. Moya-Molina, B. Oliver-Martos, C. Arrabal-Gómez, F. Rodríguez de Fonseca |
| 75 |
[GO] |
2020―Mai―06 |
SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies |
Á.I. Pérez Álvarez, C. Suárez Cuervo, S. Fernández Menéndez |
| 76 |
[GO] |
2020―Apr―23 |
Management of neurological care during the COVID-19 pandemic |
J. Matías-Guiu, J. Porta-Etessam, E. Lopez-Valdes, I. Garcia-Morales, A. Guerrero-Solá, J.A. Matias-Guiu |
| 77 |
[GO] |
2020―Apr―17 |
Should we expect neurological symptoms in the SARS-CoV-2 epidemic? |
J. Matías-Guiu, U. Gomez-Pinedo, P. Montero-Escribano, P. Gomez-Iglesias, J. Porta-Etessam, J.A. Matias-Guiu |
